0001062993-11-002347.txt : 20110523 0001062993-11-002347.hdr.sgml : 20110523 20110523183150 ACCESSION NUMBER: 0001062993-11-002347 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110519 FILED AS OF DATE: 20110523 DATE AS OF CHANGE: 20110523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Geller Matthew CENTRAL INDEX KEY: 0001446201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 11866350 MAIL ADDRESS: STREET 1: 248 CENTRAL PARK WEST CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0303 4 2011-05-19 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001446201 Geller Matthew 248 CENTRAL PARK WEST NEW YORK NY 10024 1 0 0 0 Common Stock 2011-05-19 4 S 0 400 24.1775 D 29600 D Common Stock 2011-05-20 4 S 0 10000 24.0054 D 19600 D Common Stock 2011-05-23 4 S 0 1900 24 D 17700 D This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.15 to $24.21. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.08. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Matthew Geller by Carl A. Valenstein, attorney in fact 2011-05-23